Cargando…

Is polymyxin B-immobilized fiber column ineffective for septic shock? A discussion on the press release for EUPHRATES trial

The efficacy of polymyxin B-immobilized (PMX) fiber column on septic shock is still under debate. Recently, the result from “Evaluating the Use of Polymyxin B Hemoperfusion in a Randomized controlled trial of Adults Treated for Endotoxemia and Septic shock (EUPHRATES)” trial has been announced as a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Iba, Toshiaki, Fowler, Lucy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5496228/ https://www.ncbi.nlm.nih.gov/pubmed/28690852 http://dx.doi.org/10.1186/s40560-017-0236-x

Ejemplares similares

Therapeutic Rationale for Endotoxin Removal with Polymyxin B Immobilized Fiber Column (PMX) for Septic Shock
por: Shoji, Hisataka, et al.
Publicado: (2021)

Up-to-date information on polymyxin B-immobilized fiber column direct hemoperfusion for septic shock
por: Mitaka, Chieko, et al.
Publicado: (2021)

History and current status of polymyxin B‐immobilized fiber column for treatment of severe sepsis and septic shock
por: Shimizu, Tomoharu, et al.
Publicado: (2017)

Extended duration of direct hemoperfusion with polymyxin B-immobilized fiber column improves hemodynamics in patients with septic shock
por: Yamashita, C, et al.
Publicado: (2011)

A successful application of adult polymyxin B-immobilized fiber column hemoperfusion to a neonate with septic shock
por: Kim, Young A, et al.
Publicado: (2019)

Polymyxin B-immobilized fiber column hemoperfusion mainly helps to constrict peripheral blood vessels in treatment for septic shock
por: Sugiura, Makiko, et al.
Publicado: (2015)

Polymyxin B hemoperfusion in endotoxemic septic shock patients without extreme endotoxemia: a post hoc analysis of the EUPHRATES trial
por: Klein, D. J., et al.
Publicado: (2018)

“Impact of timing of polymyxin B‐immobilized fiber column direct hemoperfusion on outcome in patients with septic shock: a single‐center observational study”
por: Tanaka, Tomoki, et al.
Publicado: (2019)

Re-evaluation of direct hemoperfusion with polymyxin-B immobilized fiber for severe sepsis and septic shock
por: Matsuo, SM, et al.
Publicado: (2011)

Removing endocannabinoids and reducing oxidative stress with polymyxin-B-immobilized fibers in patients with septic shock
por: Kase, Y, et al.
Publicado: (2007)

Clinical efficacy of long-term performance with polymyxin-B immobilized fiber treatment for septic shock
por: Matumoto, N, et al.
Publicado: (2008)

Importance of Endotoxin Clearance in Endotoxemic Septic Shock: An Analysis From the Evaluating Use of PolymyxinB Hemoperfusion in a Randomized Controlled Trial of Adults Treated for Endotoxemic Septic Shock (EUPHRATES) Trial
por: Rachoin, Jean-Sebastien, et al.
Publicado: (2020)

The wind changed direction and the big river still flows: from EUPHRATES to TIGRIS
por: Iba, Toshiaki, et al.
Publicado: (2019)

Effectiveness of polymyxin B-immobilized fiber column in sepsis: a systematic review
por: Cruz, Dinna N, et al.
Publicado: (2007)

Efficacy of direct hemoperfusion with a polymyxin B‐immobilized fiber column in miliary tuberculosis
por: Kawano, Yasumasa, et al.
Publicado: (2016)

Efficacy of polymyxin B-immobilized fiber hemoperfusion for patients with septic shock caused by Gram-negative bacillus infection
por: Saito, Nobuyuki, et al.
Publicado: (2017)

Beneficial effects of early hemoperfusion with a polymyxin B fibre column on septic shock
por: Takeyama, N, et al.
Publicado: (2009)

Endotoxin removal therapy with Polymyxin B immobilized fiber column as a COVID-19-bedside strategy protocol for endotoxic shock
por: De Rosa, Silvia, et al.
Publicado: (2022)

The EUPHRATES trial (Evaluating the Use of Polymyxin B Hemoperfusion in a Randomized controlled trial of Adults Treated for Endotoxemia and Septic shock): study protocol for a randomized controlled trial
por: Klein, David J, et al.
Publicado: (2014)

Effect of Hemoperfusion Using Polymyxin B-immobilized Fibers on Acute Lung Injury in a Rat Sepsis Model
por: Iba, Toshiaki, et al.
Publicado: (2014)

Suggestions and tips regarding polymyxin B-immobilized fiber column direct hemoperfusion of neonates with sepsis
por: Nishizaki, Naoto
Publicado: (2020)

Increase in systolic blood pressure and improvement in laboratory parameters following polymyxin B-immobilized fiber treatment in septic shock
por: Sakamoto, Y, et al.
Publicado: (2010)

Effects of endotoxin elimination therapy using polymyxin B immobilized fiber in patients with septic shock after surgical operation
por: Ikeda, T, et al.
Publicado: (1997)

Relationship between effect of polymyxin B-immobilized fiber and high-mobility group box-1 protein in septic shock patients
por: Sakamoto, Y, et al.
Publicado: (2006)

Effectiveness of polymyxin b immobilized fiber hemoperfusion in patients with septic shock due to Gram-negative bacillus infection: the PMXHP study
por: Saito, N, et al.
Publicado: (2015)

Use of Direct Hemoperfusion with Polymyxin B-Immobilized Fiber for the Treatment of Septic Shock Complicated with Lemierre Syndrome Caused by Fusobacterium necrophorum
por: Kodama, Yoshiyuki, et al.
Publicado: (2019)

Early hemoperfusion with an immobilized polymyxin B fiber column eliminates humoral mediators and improves pulmonary oxygenation
por: Kushi, Hidehiko, et al.
Publicado: (2005)

Polymyxin B-immobilized fiber column hemoperfusion has the ability of endotoxin removal during 24 hours
por: Mitaka, C, et al.
Publicado: (2012)

Hemoperfusion with an immobilized polymyxin B fiber column improves gastric mucosal pH with sepsis patients
por: Kushi, H, et al.
Publicado: (2006)

Mechanism and effectiveness of polymyxin B-immobilized fiber columns for removing mediators (HMBG-1, 2-arachidonoyl glycerol, anandamide, PAI-1, protein C and IL-6) in septic shock patients
por: Sakamoto, Y, et al.
Publicado: (2007)

Procalcitonin level as a marker of severe sepsis and septic shock patients who required polymyxin-B immobilized fiber with direct hemoperfusion
por: Ikeda, T, et al.
Publicado: (2012)

Early introduction of hemoperfusion with an immobilized polymyxin B fiber column eliminates humoral mediators and improves pulmonary oxygenation
por: Kushi, H, et al.
Publicado: (2005)

Direct hemoperfusion with polymyxin B-immobilized fiber column in a patient with acute exacerbation of idiopathic pulmonary fibrosis
por: Kim, Shin Young, et al.
Publicado: (2020)

Anti-endotoxin Properties of Polymyxin B-immobilized Fibers
por: Tani, Tohru, et al.
Publicado: (2019)

Observational study for direct hemoperfusion therapy with polymyxin-B immobilized fibers (PMX-DHP) in patients with septic shock in Japan: PMX-DHP study group
por: Kase, Y, et al.
Publicado: (2009)

Investigation of type II phospholipase A(2 )values and eicosanoid values during polymyxin-B-immobilized fiber direct hemoperfusion of septic shock patients
por: Shouzushima, T, et al.
Publicado: (2009)

Direct hemoperfusion using a polymyxin B‐immobilized polystyrene column for COVID‐19
por: Katagiri, Daisuke, et al.
Publicado: (2020)

A Case of Polymyxin b-Immobilized Fiber Column Treatment for Rapidly Progressive Interstitial Pneumonia Associated with Clinically Amyopathic Dermatomyositis
por: Sasaki, Oh, et al.
Publicado: (2013)

Polymyxin-B-immobilized-fiber column hemoperfusion with oseltamivir treatment for ARDS due to influenza H1N1/09
por: Binh, Nguyen Gia, et al.
Publicado: (2015)

Successful Recovery from COVID-19-associated Acute Respiratory Failure with Polymyxin B-immobilized Fiber Column-direct Hemoperfusion
por: Kusaba, Yusaku, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_r93aoho2m6rjh4qbre0kl799r7